Photograph Credit score: omgimages / Getty Pictures
Chest: “Delay in Recognition of Pulmonary Arterial Hypertension,” “Race and Intercourse Variations in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension.”
CDC: “Well being Disparities.”
American Lung Affiliation: “Be taught About Pulmonary Arterial Hypertension.”
Journal of the American Coronary heart Affiliation: “Mortality in Pulmonary Arterial Hypertension within the Fashionable Period: Early Insights From the Pulmonary Hypertension Affiliation Registry.”
Kingman, M., et al. Rising Consciousness about Pulmonary Arterial Hypertension Therapy for Nurses. StatPearls Publishing, 2022.
Mayo Clinic: “Pulmonary Hypertension.”
Charles Vega, MD, scientific professor of household drugs, College of California, Irvine.
Stephen C. Mathai, MD, affiliate professor, The Johns Hopkins Pulmonary Hypertension Program.
Frontiers in Ageing: “Intercourse Variations in Pulmonary Hypertension.”
Advances in Pulmonary Hypertension: “Well being Disparities in Pulmonary Arterial Hypertension and the Impression of the COVID-19 Pandemic.”
European Respiratory Assessment: “Intercourse and Gender in Pulmonary Arterial Hypertension.”
Pulmonary Circulation: “Racial and Ethnic Variations in Pulmonary Arterial Hypertension,” “Time to Prognosis of Pulmonary Hypertension and Diagnostic Burden: A Retrospective Evaluation of Nationwide U.S. Healthcare Knowledge.”
Present Issues in Cardiology: “City-Rural Disparities in Pulmonary Hypertension-Associated Mortality Between 2004 and 2019: A Name to Enhance Entry to Specialty Care Facilities for Rural Residents in the US.”
Mei-Sing Ong, PhD, assistant professor, Harvard Pilgrim Well being Care.
European Respiratory Journal: “Visitors Exposures, Air Air pollution and Outcomes in Pulmonary Arterial Hypertension: A UK Cohort Research Evaluation.”
Elizabeth Joseloff, PhD, vp of high quality care and analysis, Pulmonary Hypertension Affiliation.
Annals of the American Thoracic Society: “Secular and Regional Developments amongst Pulmonary Arterial Hypertension Medical Trial Members.”
Proceedings of the American Thoracic Society: “Sufferers with Pulmonary Arterial Hypertension in Medical Trials: Who Are They?”
American Journal of Respiratory and Essential Care Medicine: “Well being Disparities in Sufferers with Pulmonary Arterial Hypertension: A Blueprint for Motion. An Official American Thoracic Society Assertion.”
Frontiers in Drug Discovery: “Novel and Rising Therapies in Pulmonary Arterial Hypertension.”
For Lengthy-Time period Therapy of Pulmonary Arterial Hypertension, Canadian Company for Medication and Applied sciences in Well being, 2015.
BMC Well being Companies Analysis: “The Financial Burden of Pulmonary Arterial Hypertension (PAH) within the U.S. on Payers and Sufferers.”
Pulmonary Hypertension Affiliation: “Advocacy Motion Heart.”
The American Journal of Managed Care: “Well being Insurance coverage and Racial Disparities in Pulmonary Hypertension Outcomes.”